Seeking Alpha

Qiagen teams up with Amgen on companion diagnostic for AMG 510

|About: QIAGEN N.V. (QGEN)|By: , SA News Editor

QIAGEN N.V. (NYSE:QGEN) will collaborate with Amgen (NASDAQ:AMGN) to develop a tissue-based companion diagnostic for cancer candidate AMG 510. The initial work will focus on non-small cell lung cancer but the agreement allows for development for other indications.

Financial terms are not disclosed.

Try Seeking Alpha PREMIUM for unlimited analysis on QGEN